ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

LONHALA MAGNAIR
Asthma/COPD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

LONHALA MAGNAIR Rx

Generic Name and Formulations:
Glycopyrrolate 25mcg/mL; oral soln for inhalation.

Company:
Sunovion

Therapeutic Use:

RECENT UPDATES

Monograph added.

Indications for LONHALA MAGNAIR:

Long-term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema.

Adult:

For oral inhalation use only with Magnair device. Administer at the same time of the day (AM + PM). Inhale contents of one vial (25mcg) twice daily.

Children:

Not established.

Warnings/Precautions:

Do not initiate in patients during acutely deteriorating or potentially life-threatening COPD episodes. Not for treating acute symptoms. Do not exceed recommended dose. Discontinue immediately and treat if paradoxical bronchospasm or immediate hypersensitivity reactions occur; use alternative therapy. Narrow-angle glaucoma. Urinary retention. Prostatic hyperplasia. Bladder-neck obstruction. Labor & delivery. Pregnancy. Nursing mothers,

Interactions:

Additive effects with concomitant other anticholinergic-containing drugs; avoid.

Pharmacological Class:

Long-acting anticholinergic.

Adverse Reactions:

Dyspnea, urinary tract infection, wheezing, upper respiratory tract infection, nasopharyngitis, peripheral edema, fatigue; paradoxical bronchospasm, hypersensitivity reactions.

Generic Availability:

NO

How Supplied:

Kit—60 vials (w. one Magnair device)

Sign Up for Free e-newsletters